Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
life sciences
13
×
national blog main
clinical trials
national top stories
boston blog main
boston top stories
new york blog main
san francisco blog main
san francisco top stories
fda
new york top stories
san diego blog main
indiana blog main
national
san diego top stories
cancer
indiana top stories
novartis
raleigh-durham blog main
seattle blog main
texas blog main
texas top stories
boston
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
raleigh-durham top stories
roche
seattle top stories
venture capital
wisconsin blog main
wisconsin top stories
amgen
biogen
europe top stories
gene therapy
investing
What
patients
13
×
drug
medicine
fda
bio
market
roundup
cancer
daily
diabetes
friday
million
new
startup
therapy
time
today
transformed
type
acquisitions
add
advantages
ago
albert
allison
alnylam
analytics
approval
approve
approved
atrophy
awaits
bar
becker
benefiting
beta
bid
biggest
billions
biofourmis
Language
unset
unknown
Current search:
patients
×
biotech
×
" life sciences "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority